41
Tang Jiansheng, Deverich Joseph M, Miller Kenneth J Ii, Beste Russell D: Amorphous drug transdermal systems, manufacturing methods, and stabilization. Mylan Technologies, Tang Jiansheng, Deverich Joseph M, Miller Kenneth J Ii, Beste Russell D, FINETTI Thomas M, September 25, 2008: WO/2008/115371 (5 worldwide citation)

The present invention refers to a transdermal delivery device comprising a backing layer, an adhesive matrix layer comprising a supersaturated concentration of an active agent substantially in amorphous form within the adhesive matrix, and a release liner. The present invention also refers to a meth ...


42

43
Juan Mantelle, David Houze: Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures. Noven Pharmaceuticals, Foley & Lardner, December 25, 2012: US08337884 (3 worldwide citation)

A transdermal composition is disclosed which contains a blend of one or more polymers, one or more drugs, at least one of which has a low molecular weight and is liquid at or about room temperatures. The composition is substantially free of water and liquids which have a normal boiling point (a) opt ...


44
Supersaxo Andreas Werner, Weder Hans Georg, Hueglin Dietmar, Roeding Joachim Friedrich: Use of nanodispersions in pharmaceutical compositions. Ciba Sc Holding, Vesifact, November 17, 1999: EP0956853-A2 (3 worldwide citation)

Use of a nanodispersion comprising a membrane forming molecule, a co-emulsifier and a lipophilic component in pharmaceutical products. Use of a nanodispersion comprising a membrane forming molecule, a co-emulsifier and a lipophilic component in pharmaceutical products where the nanodispersion is pre ...


45
Mueller Walter Dr Dipl Chem: Transdermal system with stepwise medicament release, and its use in local or systemic medicament administration.. Lohmann Therapie Syst Lts, September 19, 1990: EP0387693-A2 (3 worldwide citation)

The invention relates to a transdermal system with stepwise medicament release and its use in local or systemic dermal administration of medicaments in human or veterinary medicine or cosmetics.


46
Rod Hartwig, David Kanios: Inhibiting crystallization of steroidal hormones in transdermal delivery systems. Noven Pharmaceuticals, Foley & Lardner, November 19, 2013: US08586080 (3 worldwide citation)

Compositions and methods for the continuous and controlled transdermal delivery of an active agent from a pharmaceutically acceptable carrier composition comprising a polyoxazoline polymer, wherein the active drug incorporated in the carrier composition of the transdermal system remains substantiall ...


47
Urtti Arto Olavi, Sutinen Marja Riitta, Paronen Timo Petteri: Transdermal drug delivery system. Urtti Arto Olavi, Sutinen Marja Riitta, Paronen Timo Petteri, January 17, 1996: GB2290964-A (3 worldwide citation)

A controlled release transdermal system for the delivery of at least one therapeutic agent comprises: a reservoir comprising (a) the therapeutic agent (eg. weak acid or base) in ionized form (b) a pH adjusting agent which upon uptake of water is converted to a buffer solution and (c) a cyclized poly ...


48
Lang Steffen: (De) Transdermales system, (En) Transdermal system. Novartis, Lang Steffen, NOVARTIS, February 13, 1997: WO/1997/004835 (3 worldwide citation)

(EN) Described is a transdermal system (1) for administering a substance through the skin (7), the system including a reservoir (3) containing the substance to be administered as an agonist (4) as well as an associated antagonist (5). The system also includes at least one electrode (2) which is pola ...


49
Takahashi Koichi, Sakai Yoshiki: Percutaneous absorption preparation. Kyorin Seiyaku, Ono Pharmaceutical Co, October 17, 2007: EP1844773-A1 (3 worldwide citation)

This present invention provides a percutaneous absorption type pharmaceutical preparation which comprises 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutylamide as the active ingredient and a backbone for transdermal system, and satisfies at least one of the following conditions (1) and (2). The pharmaceu ...


50
Carter R Anderson, Russell L Morris, Robert Cohen: Transdermal systems for the delivery of ionic agents directly to open wounds and surgically repaired incisions. Travanti Pharma, Nikolai & Mersereau P A, C G Mersereau, March 8, 2011: US07904146 (2 worldwide citation)

A transdermal system for the delivery of an anesthetic or other active therapeutic agent directly to a selected site of injured skin tissue by iontophoresis is disclosed, which utilizes a transdermal skin-worn patch including a donor electrode chamber containing a donor electrode and an amount of an ...